Header Logo

Connection

Johnny Mahlangu to Factor VIIIa

This is a "connection" page, showing publications Johnny Mahlangu has written about Factor VIIIa.
Connection Strength

0,057
  1. FRONTIER1: a partially randomized phase 2 study assessing the safety, pharmacokinetics, and pharmacodynamics of Mim8, a factor VIIIa mimetic. J Thromb Haemost. 2024 Apr; 22(4):990-1000.
    View in: PubMed
    Score: 0,057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.